Ann L. Oberg

21.8k citations

197 papers · 11.7k indexed · 1 hit paper · h-index 62

Molecular Biology top 1%
Oncology top 0.5%
Cancer Research top 0.5%
Surgery top 2%
Epidemiology top 2%

Co-authors: Sundeep Khosla Sara J. Achenbach B. Lawrence Riggs Elizabeth J. Atkinson L. Joseph Melton Gregory A. Poland Lynn C. Hartmann Douglas W. Mahoney
Topics: Pancreatic and Hepatic Oncology Research (24 papers)Ovarian cancer diagnosis and treatment (20 papers)Bone health and osteoporosis research (18 papers)
Cited by: Orthopedics and Sports Medicine Cancer Research Oncology
Journals: Science JAMA Circulation
Partner nations: United States Belarus France

In The Last Decade

Ann L. Oberg

191 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients

2002 546 citations Ann L. Oberg et al. profile →

Peers

Countries citing papers authored by Ann L. Oberg

Since Specialization

Citations

This map shows the geographic impact of Ann L. Oberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann L. Oberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann L. Oberg more than expected).

Fields of papers citing papers by Ann L. Oberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann L. Oberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann L. Oberg. The network helps show where Ann L. Oberg may publish in the future.

Co-authorship network of co-authors of Ann L. Oberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ann L. Oberg. A scholar is included among the top collaborators of Ann L. Oberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann L. Oberg. Ann L. Oberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor (PIGR) 2026 ·Clinical Cancer Research ·(unknown),(unknown),Greg Donahue,Jacob E. Till,(unknown),(unknown),William R. Bamlet,(unknown),(unknown),Ann L. Oberg,Kenneth S. Zaret	0
2	Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma 2025 ·Endocrine Related Cancer ·(unknown),Þorvarður R. Hálfdánarson,Erin E. Carlson,Kari G. Rabe,Amit Mahipal,(unknown),William R. Bamlet,(unknown),Sri Harsha Tella,Omair A. Shariq,Ryan M. Carr,Sean P. Cleary,Ann L. Oberg,Samuel O. Antwi	1
3	Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer 2025 ·OncoImmunology ·Esen Yonca Bassoy,Remya Raja,(unknown),Fabian Coscia,Krista M. Goergen,Paul M. Magtibay,Kristina Butler,Alessandra C. Schmitt,Ann L. Oberg,Marion Curtis	1
4	Identify Non-mutational p53 Functional Deficiency in Human Cancers 2024 ·Genomics Proteomics & Bioinformatics ·Qianpeng Li,Yang Zhang,Sicheng Luo,Zhang Zhang,Ann L. Oberg,David Kozono,Hua Lu,Jann N. Sarkaria,Lina Ma,Liguo Wang	0
5	Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response 2023 ·Scientific Reports ·Abigail E. Asangba,Jun Chen,Krista M. Goergen,Melissa C. Larson,Ann L. Oberg,Jvan Casarin,Francesco Multinu,Scott H. Kaufmann,Andrea Mariani,Nicholas Chia,Marina Walther-António	33
6	Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma 2021 ·Cancer Research ·Arun Kanakkanthara,Xiaonan Hou,(unknown),Valentina Zanfagnin,Amelia M. Huehls,(unknown),Husheng Ding,Melissa C. Larson,George Vasmatzis,Ann L. Oberg,Scott H. Kaufmann,Aaron S. Mansfield,S. John Weroha,Larry M. Karnitz	14
7	THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement 2020 ·Cancer Prevention Research ·(unknown),Naomi Takenaka,William R. Bamlet,Ann L. Oberg,Stephanie S. Yee,Erica L. Carpenter,Daniel S. Herman,Jung-Sun Kim,Gloria M. Petersen,Kenneth S. Zaret	16
8	The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer 2020 ·Clinical Cancer Research ·Artur A. Serebrenik,Prokopios P. Argyris,Matthew C. Jarvis,William L. Brown,Martina Bazzaro,Rachel I. Vogel,Britt Erickson,Sun Hee Lee,Krista M. Goergen,Matthew J. Maurer,Ethan P. Heinzen,Ann L. Oberg,Yajue Huang,Xiaonan Hou,S. John Weroha,Scott H. Kaufmann,Reuben S. Harris	48
9	BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents 2019 ·Cancer Research ·Arun Kanakkanthara,Kiran Kurmi,(unknown),Xiaonan Hou,(unknown),Ethan P. Heinzen,Cristina Correia,Catherine J. Huntoon,Daniel R. O’Brien,Andrea E. Wahner Hendrickson,Sean C. Dowdy,Hu Li,Ann L. Oberg,Taro Hitosugi,Scott H. Kaufmann,S. John Weroha,Larry M. Karnitz	45
10	Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes 2017 ·Clinical Cancer Research ·Chen Wang,Sebastian M. Armasu,Kimberly R. Kalli,Matthew J. Maurer,Ethan P. Heinzen,Gary L. Keeney,William A. Cliby,Ann L. Oberg,Scott H. Kaufmann,Ellen L. Goode	65
11	Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Samuel O. Antwi,William R. Bamlet,(unknown),Kari G. Chaffee,Ann L. Oberg,Aminah Jatoi,Lisa A. Boardman,Gloria M. Petersen	10
12	APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma 2016 ·Clinical Cancer Research ·Brandon Leonard,Gabriel J. Starrett,Matthew J. Maurer,Ann L. Oberg,Mieke Van Bockstal,Jo Van Dorpe,Olivier De Wever,Jozien Helleman,Anieta M. Sieuwerts,Els M.J.J. Berns,John W.M. Martens,Brett D. Anderson,William L. Brown,Kimberly R. Kalli,Scott H. Kaufmann,Reuben S. Harris	52
13	Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer 2015 ·Cancer Causes & Control ·Samuel O. Antwi,(unknown),(unknown),(unknown),Kieran Hawthorne,William R. Bamlet,Kari G. Chaffee,Ann L. Oberg,Gloria M. Petersen	87
14	Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic 2015 ·Gynecologic Oncology ·Andrea E. Wahner Hendrickson,Kieran Hawthorne,Ellen L. Goode,Kimberly R. Kalli,Krista M. Goergen,Jamie N. Bakkum‐Gamez,William A. Cliby,Gary L. Keeney,Daniel W. Visscher,Yaman Tarabishy,Ann L. Oberg,Lynn C. Hartmann,Matthew J. Maurer	16
15	Tumor Cell–Derived MMP3 Orchestrates Rac1b and Tissue Alterations That Promote Pancreatic Adenocarcinoma 2014 ·Molecular Cancer Research ·Christine Mehner,Erin Miller,(unknown),Aziza Nassar,Ann L. Oberg,William R. Bamlet,Lizhi Zhang,Jens Waldmann,Evette S. Radisky,Howard C. Crawford,Derek C. Radisky	52
16	Soft truncation thresholding for gene set analysis of RNA-seq data: Application to a vaccine study 2013 ·Scientific Reports ·Brooke L. Fridley,Gregory D. Jenkins,Diane E. Grill,Richard B. Kennedy,Gregory A. Poland,Ann L. Oberg	15
17	Abstract 11099: Transcriptome Profiling of Surgical Myectomy Tissue from Patients with Hypertrophic Cardiomyopathy Reveals Marked Overexpression of ACE2 2012 ·Circulation ·Virginia B. Hebl,J. Martijn Bos,Ann L. Oberg,(unknown),Joseph J. Maleszewski,Ozgur Ogut,Kalkidan Bishu,Cristobal G. dos Remedios,Steve R. Ommen,Hartzell V. Schaff,Joseph A. Dearani,Frank V. Brozovich,Michael J. Ackerman	2
18	Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform 2010 ·BMC Medical Genomics ·Monica M. Reinholz,Jeanette E. Eckel‐Passow,S. Keith Anderson,Yan W. Asmann,Michael A. Zschunke,Ann L. Oberg,Ann E. McCullough,Amylou C. Dueck,Beiyun Chen,Craig April,Eliza Wickham‐Garcia,Robert B. Jenkins,Julie M. Cunningham,Jin Jen,Edith A. Perez,Jian-Bing Fan,Wilma L. Lingle	11
19	Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer 2009 ·Cancer Research ·Liang Wang,Hui Tang,Venugopal Thayanithy,Subbaya Subramanian,Ann L. Oberg,Julie M. Cunningham,James R. Cerhan,Clifford J. Steer,Stephen N. Thibodeau	125
20	The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer 2006 ·Clinical Cancer Research ·Kosei Hasegawa,Takafumi Nakamura,Mary Harvey,Yasuhiro Ikeda,Ann L. Oberg,Mariangela Figini,Silvana Canevari,Lynn C. Hartmann,Kah-Whye Peng	73

About Ann L. Oberg

Ann L. Oberg is a scholar working on Reproductive Medicine, Orthopedics and Sports Medicine and Oncology, having authored 197 papers that have together received 11.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Ovarian cancer diagnosis and treatment (20 papers) and Bone health and osteoporosis research (18 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.4k citations), Cancer Research (1.7k citations) and Oncology (2.8k citations). Ann L. Oberg has collaborated with scholars based in United States, Belarus and France. Frequent co-authors include Sundeep Khosla, Sara J. Achenbach, B. Lawrence Riggs, Elizabeth J. Atkinson, L. Joseph Melton, L. Joseph Melton, Gregory A. Poland, Lynn C. Hartmann, Douglas W. Mahoney and L. Joseph Melton. Their work appears in journals such as Science, JAMA and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact